1.Broder KR, Cortese MM, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1–34.
2.National, state, and urban area vaccination coverage among children aged 19-35 months—United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:658–661.
3.Kurt TL, Yeager AS, Guenette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972;221:264–267.
4.Outbreaks of pertussis associated with hospitals—Kentucky, Pennsylvania, and Oregon, 2003. MMWR Morb Mortal Wkly Rep 2005; 54:67–71.
5.Addiss DG, Davis JP, Meade BD, et al. A pertussis outbreak in a Wisconsin nursing home. J Infect Dis 1991; 164:704–710.
6.Bassinet L, Matrat M, Njamkepo E, Aberrane S, Housset B, Guiso N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect Control Hosp Epidemiol 2004; 25:995–997.
7.Boulay BR, Murray CJ, Ptak J, Kirkland KB, Montero J, Talbot EA. An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol 2006; 27: 92–95.
8.Gehanno JF, Pestel-Caron M, Nouvellon M, Caillard JE. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect Control Hosp Epidemiol 1999; 20:549–552.
9.Karino T, Osaki K, Nakano E, Okimoto N. A pertussis outbreak in a ward for the severely retarded [in Japanese]. Kansenshogaku Zasshi 2001; 75:916–922.
10.Steketee RW, Wassilak SG, Adkins WN Jr, et al. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988; 157:434–440.
11.Weber DJ, Rutala WA. Pertussis: an underappreciated risk for nosocomial outbreaks. Infect Control Hosp Epidemiol 1998; 19:825–828.
12.De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182:174–179.
13.Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol 1999; 20:120–123.
14.Ward A, Caro J, Bassinet L, Housset B, O'Brien JA, Guiso N. Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect Control Hosp Epidemiol 2005; 26:288–292.
15.Calugar A, Ortega-Sanchez IR, Tiwari T, Oakes L, Jahre JA, Murphy TV. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006; 42:981–988.
16.Bryant K, Humbaugh K, Brothers K, et al. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. Infect Control Hosp Epidemiol 2006; 27:541–545 (in this issue).
17.Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J 2006; 25: 361–362.
18.Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32:1691–1697.
19.Hewlett EL, Edwards KM. Clinical practice. Pertussis—not just for kids. N Engl J Med 2005; 352:1215–1222.
20.Bamberger E, Starets-Haham O, Greenberg D, et al. Adult pertussis is hazardous for the newborn. Infect Control Hosp Epidemiol 2006; 27: 623–625 (in this issue).
21.Tiwari T, Murphy TV, Moran J. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep 2005; 54:1–16.
22.Giugliani C, Vidal-Trécan G, Traore S, et al. Feasibility of azithromycin prophylaxis during a pertussis outbreak among healthcare workers in a university hospital in Paris. Infect Control Hosp Epidemiol 2006; 27: 626–629 (in this issue).
23.Güriş D. Treatment and chemoprophylaxis [chapter 3, amended]. In: National Immunization Program, Centers for Disease Control and Prevention. Guidelines for the Control of Pertussis Outbreaks, 2000. Available at: http://www.cdc.gov/nip/publications/pertussis/guide.htm. Accessed April 12, 2006.
25.Devasia RA, Jones TF, Collier B, Schaffher W. Compliance with erythromycin versus azithromycin during a pertussis outbreak—Tennessee, 2004. In: Program and abstracts of the 43rd Annual Meeting of the Infectious Diseases Society of America; October 6-9,2005; San Francisco, CA. Abstract 340.
26.Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention. ACIP votes to recommend use of combined tetanus, diphtheria and pertussis (Tdap) vaccine for adults. March 2, 2006. Available at: http://www.cdc.gov/nip/vaccine/tdap/. Accessed on April 12, 2005.
27.Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555–1563.
28.Campins-Marti M, Cheng HK, Forsyth K, et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2001; 20:641–646.
29.Plotkin S. The global pertussis initiative: process overview. Pediatr Infect Dis J 2005; 24:S7–S9.
30.Talbot TR, Bradley SE, Cosgrove SE, Ruef C, Siegel JD, Weber DJ. Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol 2005; 26:882–890.